March 01, 2015 6:30 PM ET

Pharmaceuticals

Company Overview of N30 Pharmaceuticals, Inc.

Key Executives for N30 Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jon Congleton 11 RelationshipsChief Executive Officer, President and Director--
R. Michael Carruthers 14 RelationshipsChief Financial Officer56
Janice Troha No RelationshipsExecutive Vice President of Product Development & Regulatory--
Sherif Gabriel Ph.D.No RelationshipsVice President of Research--

N30 Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Howard P. Furst M.D. 17 RelationshipsDeerfield Management Company, L.P.47
Jon Congleton 11 RelationshipsN30 Pharmaceuticals, Inc.--
Joseph Loscalzo M.D., Ph.D. 106 RelationshipsNitroMed, Inc.62
Arnold Snider 95 RelationshipsN30 Pharmaceuticals, Inc.--
Charles H. Scoggin M.D. 11 RelationshipsCorgenix Medical Corp.69
View All Board Members

N30 Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Joseph Loscalzo106 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
382.3K
Bonus
530.9K
Total Short Term Compensation
596.0K
Total Value of Options
13.3M
Compensation as of Fiscal Year
N30 Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

SCA Appoints Linda Nyberg as Vice President of Media Relations and Online Communications
February 26, 2015 12:00 AM ET
Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET
Spectrum Brands Holdings, Inc. Elects Joseph S. Steinberg as Director
February 20, 2015 9:11 PM ET
John R. Alm Announces Not to Stand for Re-Election as a Director of Kimberly-Clark Corporation
February 20, 2015 2:59 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N30 Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.